Prevalence of echocardiographic features suggesting cardiac sarcoidosis in patients with pacemaker or implantable cardiac defibrillator

Korean Circulation Journal

Volumn 41, Issue 6, 2011, Pages 313-320

  Sun, Byung Joo ^a   Lee, Pil Hyung ^a   Choi, Hyung Oh ^a   Ahn, Jung Min ^a   Seo, Jeong Sook ^a   Kim, Dae Hee ^a   Song, Jong Min ^a   Choi, Kee Joon ^a   Kang, Duk Hyun ^a   Song, Jae Kwan ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Echocardiography; Implantable cardioverter defibrillators; Pacemaker; Sarcoidosis

Indexed keywords

PREDNISOLONE;

ADULT; AGED; AKINESIA; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; DEATH; DEFIBRILLATOR; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; HEART MUSCLE BIOPSY; HEART SARCOIDOSIS; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LUNG SARCOIDOSIS; LYMPH NODE; LYMPH NODE SARCOIDOSIS; MALE; PACEMAKER; SARCOIDOSIS;

EID: 79960602401     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.6.313     Document Type: Article

References (22)

1. Dubrey SW, BellA, Mittal TK. Sarcoid heart disease. Postgrad Med J 2007;83:618-23.
2. Bargout R, Kelly RF. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 2004;97:173-82.
3. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996;10:495-510.
4. Lewin RF, Mor R, Spitzer S, Arditti A, Hellman C, Agmon J. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985;110:116-22.
5. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108.
6. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselecled patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
7. Yamano T, Nakatani S. Cardiac sarcoidosis: what can we know from echocardiography? J Echocardiogr 2007;5:1-10.
8. Hiraga H, Yuwai K, Hiroe M. Guidelines for the diagnosis of cardiac sarcoidosis: study report of diffuse pulmonary diseases. Tokyo: Japanese Ministry of Health and Welfare; 1993. p. 23-4.
9. Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 1992;124:383-4.
10. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects inpatients with sarcoidosis. Am J Med 1988;85:189-93.
11. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41.
12. Kim DS. Sarcoidosis in Korea: report of the Second Nationwide Survey. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:176-80.
13. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-69.
14. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-52.
15. Choi JH, Kim J, Park TI, et al. Two cases of an implantation of a permanent pacemaker using a transaxillary incision. Korean Circ J 2008;38:500-4.
16. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.
17. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:75-86.
18. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.
19. Nelson JE, Kirschner PA, Teirstein AS. Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:178-82.
20. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005;95:143-6.
21. Valantine H, McKenna WJ, Nihoyannopoulos P, et al. Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J 1987;57:256-63.
22. Cho YK. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Korean Circ J 2008;38:514-23.